Bayer Sees Significant, But Smaller, Asundexian Opportunity

BMS Still Confident In Competing Asset Milvexian

 
• By Mandy Jackson
Heart activity on monitor in intensive care unit
Bayer sees significant opportunity for asundexian in stroke despite AF miss • Source: Shutterstock

More from Clinical Trials

More from R&D